Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Ann Hematol

Retrieve available abstracts of 148 articles:
HTML format

Single Articles

    December 2022
  1. ZHANG JY, Li Y, Ma YS, Sun XJ, et al
    Clinical characteristics and prognostic factors in intracranial hemorrhage patients with hematological diseases.
    Ann Hematol. 2022;101:2617-2625.
    PubMed     Abstract available

    November 2022
  2. FUTAGI Y, Suga Y, Shimada T, Sai Y, et al
    Impact of antithymocyte globulin on blood cyclosporin A levels in aplastic anemia patients.
    Ann Hematol. 2022 Nov 26. doi: 10.1007/s00277-022-05063.

  3. MUSALLAM KM, Cappellini MD, Daar S, El-Beshlawy A, et al
    Magnitude of cumulative iron overload correlates with the severity of anemia in untreated non-transfusion-dependent beta-thalassemia.
    Ann Hematol. 2022 Nov 14. pii: 10.1007/s00277-022-05046.

  4. DELEHAYE F, Rouger J, Brossier D, Suttorp M, et al
    Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course.
    Ann Hematol. 2022 Nov 12. pii: 10.1007/s00277-022-05024.
    PubMed     Abstract available

  5. BANZIGER S, Weisshaar K, Arokoski R, Gerull S, et al
    Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria-a pilot study (ePRO-AA-PNH).
    Ann Hematol. 2022 Nov 3. pii: 10.1007/s00277-022-05012.
    PubMed     Abstract available

  6. PIATTI G, Giuditta M, Consonni D, Cassinerio E, et al
    Cardiopulmonary testing in adult patients with beta-thalassemia major in comparison to healthy subjects.
    Ann Hematol. 2022;101:2445-2452.
    PubMed     Abstract available

  7. ZHANG R, Chen M, Yang C, Han B, et al
    Efficacy and steroid-sparing effect of tacrolimus in patients with autoimmune cytopenia.
    Ann Hematol. 2022;101:2421-2431.
    PubMed     Abstract available

  8. HAN B, Ji J, Zhang B, Bai H, et al
    The first successful expanded compassionate use of Iptacopan in a patient with paroxysmal nocturnal hemoglobinuria.
    Ann Hematol. 2022;101:2537-2539.

    October 2022
  9. FAN J, Lu R, Yu K, Zhang Y, et al
    Very severe aplastic anemia with papillary thyroid carcinoma: treatment with allo-HSCT-a case report and literature review.
    Ann Hematol. 2022 Oct 21. pii: 10.1007/s00277-022-05009.

  10. YANG W, Zhao X, He G, Chang H, et al
    Iron chelation of hetrombopag in aplastic anemia: a post hoc analysis of a phase II study.
    Ann Hematol. 2022 Oct 11. pii: 10.1007/s00277-022-04968.
    PubMed     Abstract available

  11. ROTH A, Barcellini W, Tvedt THA, Miyakawa Y, et al
    Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study.
    Ann Hematol. 2022;101:2169-2177.
    PubMed     Abstract available

  12. THEDSAWAD A, Wanachiwanawin W, Taka O, Hantaweepant C, et al
    Cut-off values for diagnosis of G6PD deficiency by flow cytometry in Thai population.
    Ann Hematol. 2022;101:2149-2157.
    PubMed     Abstract available

  13. LIU XD, Yang K, Xiao J, Huang H, et al
    Whole exome sequencing identifies a novel SPTB frameshift mutation causing hereditary spherocytosis in the Chinese population.
    Ann Hematol. 2022;101:2355-2357.

    September 2022
  14. HU J, Zhang L, Zhao X, Liu X, et al
    First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years' experience.
    Ann Hematol. 2022 Sep 24. pii: 10.1007/s00277-022-04952.
    PubMed     Abstract available

  15. EL-AMIN N, Iness A, Cyrus JW, Sisler I, et al
    Anticoagulation strategies and recurrence of venous thromboembolic events in patients with sickle cell disease: a systematic review and meta-analysis.
    Ann Hematol. 2022;101:1931-1940.
    PubMed     Abstract available

  16. CELLA D, Sarda SP, Hsieh R, Fishman J, et al
    Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase III PEGASUS study.
    Ann Hematol. 2022;101:1905-1914.
    PubMed     Abstract available

  17. WONG RSM, Pullon HWH, Amine I, Bogdanovic A, et al
    Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria.
    Ann Hematol. 2022;101:1971-1986.
    PubMed     Abstract available

  18. PADRAO EMH, Bustos B, Mahesh A, Fonseca GHH, et al
    Phenotypes of sickle cell intensive care admissions: an unsupervised machine learning approach in a single-center retrospective cohort.
    Ann Hematol. 2022;101:1951-1957.
    PubMed     Abstract available

  19. MELONI A, Barbuto L, Pistoia L, Positano V, et al
    Frequency, pattern, and associations of renal iron accumulation in sickle/beta-thalassemia patients.
    Ann Hematol. 2022;101:1941-1950.
    PubMed     Abstract available

    August 2022
  20. JIN Y, Li R, Lin S, Jia J, et al
    A real-word experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia.
    Ann Hematol. 2022 Aug 27. pii: 10.1007/s00277-022-04966.
    PubMed     Abstract available

  21. BEYAR-KATZ O, Perry C, On YB, Amit O, et al
    Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells-single-center experience.
    Ann Hematol. 2022;101:1769-1776.
    PubMed     Abstract available

  22. ZHOU F, Zhang F, Zhang L, Wu Q, et al
    A multicentre trial of intensive immunosuppressive therapy combined with umbilical cord blood for the treatment of severe aplastic anaemia.
    Ann Hematol. 2022;101:1785-1794.
    PubMed     Abstract available

  23. PIRIYAKHUNTORN P, Tantiworawit A, Kasitanon N, Louthrenoo W, et al
    Prevalence and characteristics of inflammatory rheumatic diseases in patients with thalassemia.
    Ann Hematol. 2022;101:1667-1675.
    PubMed     Abstract available

  24. JAFRI F, Seong G, Jang T, Cimpeanu E, et al
    L-glutamine for sickle cell disease: more than reducing redox.
    Ann Hematol. 2022;101:1645-1654.
    PubMed     Abstract available

  25. LOBITZ S, Frommel C, Brose A, Blankenstein O, et al
    Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol.
    Ann Hematol. 2022;101:1859-1860.

    July 2022
  26. AL-KURAISHY HM, Al-Gareeb AI, Kaushik A, Kujawska M, et al
    Hemolytic anemia in COVID-19.
    Ann Hematol. 2022 Jul 8. pii: 10.1007/s00277-022-04907.
    PubMed     Abstract available

  27. HAN B, Kim HJ, Yhim HY, Oh D, et al
    Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study.
    Ann Hematol. 2022;101:1435-1445.
    PubMed     Abstract available

  28. JUNG EH, Park JH, Hwan Kim K, Kim JS, et al
    Characteristics of Sweet syndrome in patients with or without malignancy.
    Ann Hematol. 2022;101:1499-1508.
    PubMed     Abstract available

  29. ROPERO P, Gonzalez Fernandez FA, Nieto JM, Recasens V, et al
    Does size matter? Two new deletions in the HBB gene cause beta(0)-thalassemia.
    Ann Hematol. 2022;101:1465-1471.
    PubMed     Abstract available

  30. WU X, Cheng L, Liu X, Sun Y, et al
    Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia.
    Ann Hematol. 2022;101:1493-1498.
    PubMed     Abstract available

  31. PATSOURAKOS D, Aggeli C, Gatzoulis KA, Delicou S, et al
    Left atrial deformation indices in beta-thalassemia major patients.
    Ann Hematol. 2022;101:1473-1483.
    PubMed     Abstract available

  32. ADAM AS, Cotton F, Cantinieaux B, Benyaich S, et al
    Screening for hereditary spherocytosis in daily practice: what is the best algorithm using erythrocyte and reticulocyte parameters?
    Ann Hematol. 2022;101:1485-1491.
    PubMed     Abstract available

  33. COSTANTINI S, Meloni A, Spasiano A, Cinque P, et al
    The unexpected impact of cabozantinib on red blood cells consumption in patients with transfusion-dependent thalassemia.
    Ann Hematol. 2022;101:1621-1623.

    June 2022
  34. MA X, Zuo Y, Xu Z, Zhang Y, et al
    Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemia.
    Ann Hematol. 2022 Jun 23. pii: 10.1007/s00277-022-04885.
    PubMed     Abstract available

  35. HWANG YY, Chan TSY, Chan FHY, Lau CWP, et al
    Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy.
    Ann Hematol. 2022;101:1163-1172.
    PubMed     Abstract available

  36. ZHOU X, Jiang P, Gao L, Yang J, et al
    Immune reconstitution and survival of patients with parvovirus B19 related pure red cell aplasia after haplo-PBSCT.
    Ann Hematol. 2022;101:1333-1342.
    PubMed     Abstract available

  37. ESCRIBANO SERRAT S, Del Campo Balguerias G, Martinez Nieto J, Medina Salazar F, et al
    Pincered red cells in hereditary spherocytosis.
    Ann Hematol. 2022;101:1393-1394.

    May 2022
  38. PIRES DA SILVA BGP, Fonseca NP, Catto LFB, Pereira GC, et al
    The spectrum of paroxysmal nocturnal hemoglobinuria clinical presentation in a Brazilian single referral center.
    Ann Hematol. 2022;101:999-1007.
    PubMed     Abstract available

  39. POPLAWSKA M, Dutta D, Jayaram M, Chong NS, et al
    Genes modulating intestinal permeability and microbial community are dysregulated in sickle cell disease.
    Ann Hematol. 2022;101:1009-1013.
    PubMed     Abstract available

    April 2022
  40. KAYNAR LA, Gokcen S, Can F, Yegin ZA, et al
    Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia.
    Ann Hematol. 2022 Apr 23. pii: 10.1007/s00277-022-04835.
    PubMed     Abstract available

  41. WERNER R, Lohr B, Lodemann P, Chemnitz JM, et al
    Autoimmune basal ganglia encephalitis with hemolytic anemia.
    Ann Hematol. 2022 Apr 21. pii: 10.1007/s00277-022-04848.

  42. PROCHASKA MT, Huisingh-Scheetz M, Meltzer D
    Sex differences in fatigue and symptoms of anemia in relation to hemoglobin level in hospitalized patients.
    Ann Hematol. 2022 Apr 11. pii: 10.1007/s00277-022-04830.

  43. LI S, Guo P, Mi L, Chai X, et al
    A novel SPTB mutation causes hereditary spherocytosis via loss-of-function of beta-spectrin.
    Ann Hematol. 2022;101:731-738.
    PubMed     Abstract available

    March 2022
  44. BAHATI YL, Delanghe J, Balaluka GB, Philippe J, et al
    Exploration of the relationship between anemia and iron and zinc deficiencies in children under 5 years of age living in the malaria endemic area of South Kivu/Democratic Republic of Congo.
    Ann Hematol. 2022 Mar 23. pii: 10.1007/s00277-022-04816.
    PubMed     Abstract available

  45. TOLU SS, Crouch A, Choi J, Gao Q, et al
    Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease.
    Ann Hematol. 2022;101:541-548.
    PubMed     Abstract available

  46. LUFTINGER R, Zubarovskaya N, Galimard JE, Cseh A, et al
    Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major.
    Ann Hematol. 2022;101:655-665.
    PubMed     Abstract available

  47. BAYRAKTAROGLU S, Karadas N, Onen S, Karapinar DY, et al
    Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study.
    Ann Hematol. 2022;101:521-529.
    PubMed     Abstract available

  48. SOULIERES D, Mercier-Ross J, Fradette C, Rozova A, et al
    The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease.
    Ann Hematol. 2022;101:533-539.
    PubMed     Abstract available

  49. LI S, Chen K, Huang C, Zhang N, et al
    First report of successful treatment for hemoglobin Bristol-Alesha by hemopoietic stem cell transplantation.
    Ann Hematol. 2022;101:617-619.
    PubMed     Abstract available

  50. ROSETTI M, De la Salle B, Farneti G, Clementoni A, et al
    The added value of digital morphological analysis in the evaluation of peripheral blood films: the report of an UKNEQAS external quality assessment sample.
    Ann Hematol. 2022;101:729-730.

  51. FARFAN-QUIROGA G, Hermosilla-Fernandez MDM, Feliu-Sanchez J, Najera-Irazu MJ, et al
    A new case of Bicetre hemoglobin in an adult male: clinical observations over a period of four years.
    Ann Hematol. 2022;101:701-702.

    February 2022
  52. VIROT E, Thuret I, Jardel S, Herbrecht R, et al
    Pregnancy outcome in women with transfused beta-thalassemia in France.
    Ann Hematol. 2022;101:289-296.
    PubMed     Abstract available

  53. MARTINS SR, Toledo SLO, da Silva AJ, Mendes FS, et al
    Endothelial dysfunction biomarkers in sickle cell disease: is there a role for ADMA and PAI-1?
    Ann Hematol. 2022;101:273-280.
    PubMed     Abstract available

  54. DINGLI D, Matos JE, Lehrhaupt K, Krishnan S, et al
    The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey.
    Ann Hematol. 2022;101:251-263.
    PubMed     Abstract available

  55. HOSOKAWA K, Nakao S
    Assay sensitivity of flow cytometric PNH analysis: response to Brando and Gatti.
    Ann Hematol. 2022;101:461-464.

  56. BRANDO B, Gatti A
    Re: Hosokawa K et al. Assay sensitivity of flow cytometric PNH analysis.
    Ann Hematol. 2022;101:459-460.

  57. DAS S, Karmakar K, Mukherjee R, Panda S, et al
    Acute stroke in young adult secondary to moyamoya angiopathy unveiling HbE-beta thalassemia.
    Ann Hematol. 2022;101:449-451.

    January 2022
  58. SUN YX, Feng Q, Wang SW, Li X, et al
    HLA-G-ILT2 interaction contributes to suppression of bone marrow B cell proliferation in acquired aplastic anemia.
    Ann Hematol. 2022 Jan 18. pii: 10.1007/s00277-022-04757.
    PubMed     Abstract available

  59. GHANEM P, Marrone K, Shanbhag S, Brahmer JR, et al
    Current challenges of hematologic complications due to immune checkpoint blockade: a comprehensive review.
    Ann Hematol. 2022;101:1-10.
    PubMed     Abstract available

  60. YILDIRIM N, Unal S, Yalcinkaya A, Karahan F, et al
    Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome.
    Ann Hematol. 2022;101:35-41.
    PubMed     Abstract available

  61. SOKOL J, Guman T, Chudej J, Hlebaskova M, et al
    Ixazomib, lenalidomide, and dexamethasone combination in "real-world" clinical practice in patients with relapsed/refractory multiple myeloma.
    Ann Hematol. 2022;101:81-89.
    PubMed     Abstract available

  62. ABULHAMAIL A, AlShebli A, Merdad L, Wali S, et al
    Prevalence of and risk factors for obstructive sleep apnea in children with sickle cell: a multicentric cross sectional study.
    Ann Hematol. 2022;101:43-57.
    PubMed     Abstract available

  63. TARTAGLIONE I, Manara R, di Concilio R, Quarta A, et al
    Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds.
    Ann Hematol. 2022;101:241-242.

  64. MUSALLAM KM, Cappellini MD, Daar S, Taher AT, et al
    Morbidity-free survival and hemoglobin level in non-transfusion-dependent beta-thalassemia: a 10-year cohort study.
    Ann Hematol. 2022;101:203-204.

  65. ACQUAVIVA G, Nonne G, Murtas A, Longu F, et al
    Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia.
    Ann Hematol. 2022;101:227-228.

  66. DEBUREAUX PE, Ruggiu M, Mathis S, Mirouse A, et al
    Aggressive lymphoma, hemophagocytic lymphohistiocytosis, and G6PD crisis: a lytic cocktail.
    Ann Hematol. 2022;101:219-221.

    December 2021
  67. EL-KHAZRAGY N, Matbouly S, Hanna DH, Mahran NA, et al
    Circulating miRNAs and tissue iron overload in transfusion-dependent beta-thalassemia major: novel predictors and follow-up guide.
    Ann Hematol. 2021;100:2909-2917.
    PubMed     Abstract available

  68. KARIMI M, Zarei T, Bahmanimehr A, Aramesh A, et al
    Long-term safety and efficacy of hydroxyurea in patients with non-transfusion-dependent beta-thalassemia: a comprehensive single-center experience.
    Ann Hematol. 2021;100:2901-2907.
    PubMed     Abstract available

    November 2021
  69. VIVES-CORRONS JL, Krishnevskaya E, Hernandez-Rodriguez I, Payan-Pernia S, et al
    Red cell ektacytometry in two patients with chronic hemolytic anemia and three new alpha-spectrin variants.
    Ann Hematol. 2021 Nov 29. pii: 10.1007/s00277-021-04723.
    PubMed     Abstract available

  70. JIANG Z, Jiang X, Chen M
    Severe aplastic anemia in a patient with erythropoietic protoporphyria successfully treated by avatrombopag.
    Ann Hematol. 2021 Nov 26. pii: 10.1007/s00277-021-04726.

  71. MATSUYAMA Y, Hosoi H, Horitani R, Kawamoto S, et al
    Management of warm autoimmune hemolytic anemia related to band 3-positive colon carcinoma.
    Ann Hematol. 2021 Nov 5. pii: 10.1007/s00277-021-04714.

  72. DUCA L, Nava I, Tavazzi D, Marcon A, et al
    Epidemiological shift of glucose-6-phosphate dehydrogenase mutations in northern Italy in the last 15 years.
    Ann Hematol. 2021;100:2683-2688.
    PubMed     Abstract available

  73. KULAGIN AD, Ptushkin VV, Lukina EA, Davydkin IL, et al
    Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab.
    Ann Hematol. 2021;100:2689-2698.
    PubMed     Abstract available

  74. TEAWTRAKUL N, Chansai S, Yamsri S, Ungarreevittaya P, et al
    JAK2V617F mutation in patients with beta-thalassemia disease: prevalence and clinical characteristics.
    Ann Hematol. 2021;100:2863-2865.

    October 2021
  75. EL FAKIH R, Alfraih F, Alhayli S, Ahmed SO, et al
    Frontline-matched sibling donor transplant of aplastic anemia patients using primed versus steady-state bone marrow grafts.
    Ann Hematol. 2021 Oct 31. pii: 10.1007/s00277-021-04708.
    PubMed     Abstract available

  76. BIASSI TP, Guerra-Shinohara EM, Moretti PNS, de Freitas Dutra V, et al
    miRNA profile and disease severity in patients with sickle cell anemia.
    Ann Hematol. 2021 Oct 22. pii: 10.1007/s00277-021-04665.
    PubMed     Abstract available

  77. PEREIRA-MARTINS DA, Coelho-Silva JL, Domingos IF, Weinhauser I, et al
    The ratio of ATP11C/PLSCR1 mRNA transcripts has clinical significance in sickle cell anemia.
    Ann Hematol. 2021 Oct 14. pii: 10.1007/s00277-021-04696.
    PubMed     Abstract available

  78. SHOKRGOZAR N, Karimi M, Golmoghaddam H, Rezaei N, et al
    Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in beta-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype.
    Ann Hematol. 2021;100:2463-2469.
    PubMed     Abstract available

  79. ABDULHAI F, Jaffa MA, Elias J, Zakka P, et al
    Digital thermography and vascular involvement in beta-thalassemia intermedia.
    Ann Hematol. 2021;100:2471-2477.
    PubMed     Abstract available

    September 2021
  80. HIRAMOTO N, Yamazaki H, Nakamura Y, Uchida N, et al
    Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation.
    Ann Hematol. 2021 Sep 21. pii: 10.1007/s00277-021-04664.
    PubMed     Abstract available

  81. THONG EWS, Tan SS, Sethi SK, Chee YL, et al
    Falsely elevated serum vitamin B12 levels in a case of pernicious anemia.
    Ann Hematol. 2021 Sep 10. pii: 10.1007/s00277-021-04612.

  82. WOUTERS HJCM, Conrads-Frank A, Koinig KA, Smith A, et al
    The anemia-independent impact of myelodysplastic syndromes on health-related quality of life.
    Ann Hematol. 2021 Sep 2. pii: 10.1007/s00277-021-04654.
    PubMed     Abstract available

  83. JANG T, Mo G, Stewart C, Khoury L, et al
    Obesity and diabetes mellitus in patients with sickle cell disease.
    Ann Hematol. 2021;100:2203-2205.
    PubMed     Abstract available

  84. BOGA C, Asma S, Leblebisatan G, Sen N, et al
    Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.
    Ann Hematol. 2021;100:2195-2202.
    PubMed     Abstract available

    August 2021
  85. CHENOU F, Hounkpe BW, Domingos IF, Tonasse WV, et al
    Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients.
    Ann Hematol. 2021 Aug 28. pii: 10.1007/s00277-021-04636.
    PubMed     Abstract available

  86. YAMADA S, Kajikawa S, Nakagawa N, Kondo Y, et al
    Coombs' test positive autoimmune hemolytic anemia accompanied by myelodysplastic syndrome that became Coombs' test negative after azacitidine administration.
    Ann Hematol. 2021 Aug 27. pii: 10.1007/s00277-021-04652.

  87. ATIPIMONPAT A, Siwaponanan P, Khuhapinant A, Svasti S, et al
    Extracellular vesicles from thalassemia patients carry iron-containing ferritin and hemichrome that promote cardiac cell proliferation.
    Ann Hematol. 2021;100:1929-1946.
    PubMed     Abstract available

  88. TRANEKAER S, Hansen DL, Biemond BJ, Sorensen AL, et al
    Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study.
    Ann Hematol. 2021;100:1947-1951.
    PubMed     Abstract available

  89. SINGHA K, Fucharoen G, Fucharoen S
    delta-Hemoglobinopathies in Thailand: screening, molecular basis, genotype-phenotype interaction, and implication for prevention and control of thalassemia.
    Ann Hematol. 2021;100:1953-1963.
    PubMed     Abstract available

  90. HOSOKAWA K, Ishiyama K, Ikemoto T, Sugimori C, et al
    The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure.
    Ann Hematol. 2021;100:1975-1982.
    PubMed     Abstract available

  91. OKAMOTO H, Uoshima N, Kamitsuji Y, Kawata E, et al
    Paroxysmal nocturnal hemoglobinuria complicated with essential thrombocythemia harboring concomitant PIGA, CALR, and ASXL1 mutations.
    Ann Hematol. 2021;100:2113-2115.

  92. ROBIER C, Hoefler G, Aubell K, Hubmann E, et al
    Acquired elliptocytosis as presenting sign of a myelodysplastic syndrome associated with deletion of chromosome 20 and mutations in TET2, DNMT3A, and U2AF1.
    Ann Hematol. 2021;100:2111-2112.

  93. JAMWAL M, Mallik N, Aravindan AV, Jain A, et al
    Hemolytic erythrocytosis: an amalgamated phenotype from coinherited Chuvash polycythemia and G6PD Kerala-Kalyan with acquired transient stomatocytosis.
    Ann Hematol. 2021;100:2107-2109.

    July 2021
  94. NORASETTHADA L, Wongkhantee S, Chaipokam J, Charoenprasert K, et al
    Adult aplastic anemia in Thailand: incidence and treatment outcome from a prospective nationwide population-based study.
    Ann Hematol. 2021 Jul 16. pii: 10.1007/s00277-021-04566.
    PubMed     Abstract available

  95. YANG W, Zhao X, Peng G, Zhang L, et al
    Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia.
    Ann Hematol. 2021 Jul 16. pii: 10.1007/s00277-021-04553.
    PubMed     Abstract available

  96. CAO J, Pei R, Zhang P, Liu X, et al
    Successful haploidentical transplantation using plasma exchange and post-transplantation cyclophosphamide for severe aplastic anemia patients with anti-human leukocyte antigen donor-specific antibodies.
    Ann Hematol. 2021 Jul 6. pii: 10.1007/s00277-021-04497.
    PubMed     Abstract available

  97. GOREN SAHIN D, Akay OM, Keklik M, Okan V, et al
    Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience.
    Ann Hematol. 2021;100:1667-1675.
    PubMed     Abstract available

  98. ELZAEEM DI, Sharkawi EAE, Zaki EM, Ghobrial AG, et al
    Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients.
    Ann Hematol. 2021;100:1701-1709.
    PubMed     Abstract available

  99. NJUE L, Medri C, Keller P, Diepold M, et al
    The rare hemoglobin variant Hb Mizuho: report of a Swiss family and literature review.
    Ann Hematol. 2021;100:1677-1683.
    PubMed     Abstract available

  100. RICCHI P, Costantini S, Spasiano A, Cinque P, et al
    Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity.
    Ann Hematol. 2021;100:1907-1910.

  101. MUSALLAM KM, Cappellini MD, Taher AT
    Variations in hemoglobin level and morbidity burden in non-transfusion-dependent beta-thalassemia.
    Ann Hematol. 2021;100:1903-1905.

  102. TRAN QUANG V, Tarfi S, Loustau V, Moutereau S, et al
    A belated diagnosis of G6PD deficiency in an 81-year-old woman.
    Ann Hematol. 2021;100:1901-1902.

    June 2021
  103. BATISTA JVGF, Pereira-Martins DA, Falcao DA, Domingos IF, et al
    Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia.
    Ann Hematol. 2021 Jun 14. pii: 10.1007/s00277-021-04532.
    PubMed     Abstract available

  104. KRECAK I, Cengic M, Skoric I, Nakic M, et al
    Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib.
    Ann Hematol. 2021 Jun 10. pii: 10.1007/s00277-021-04570.

  105. AL-TAWFIQ JA, Rabaan AA, AlEdreesi MH
    Frequency of bacteremia in patients with sickle cell disease: a longitudinal study.
    Ann Hematol. 2021;100:1411-1416.
    PubMed     Abstract available

  106. ARPACI A, Gul BU, Ozcan O, Ilhan G, et al
    Presentation of two new mutations in the 3'untranslated region of the beta-globin gene and evaluating the molecular spectrum of thalassemia mutations in the Mediterranean region of Turkey.
    Ann Hematol. 2021;100:1429-1438.
    PubMed     Abstract available

  107. BHURANI D, Kapoor J, Yadav N, Khushoo V, et al
    Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients.
    Ann Hematol. 2021;100:1417-1427.
    PubMed     Abstract available

  108. MAROUF R, Adekile AD, El-Muzaini H, Abdulla R, et al
    Neutrophil gelatinase-associated lipocalin as a biomarker of nephropathy in sickle cell disease.
    Ann Hematol. 2021;100:1401-1409.
    PubMed     Abstract available

  109. TAMAI Y, Ito S, Hasegawa A
    Paroxysmal nocturnal haemoglobinuria associated with a novel phosphatidylinositol glycan class A (PIGA) mutation in a patient with Klinefelter syndrome.
    Ann Hematol. 2021;100:1625-1627.

    May 2021
  110. HERBRETEAU L, Le Calloch R, Arnaud B, Cassou N, et al
    Eculizumab, a real-life successful treatment for refractory cold agglutinin-mediated auto-immune hemolytic anemia secondary to lymphoproliferative disorders.
    Ann Hematol. 2021 May 18. pii: 10.1007/s00277-021-04557.

  111. QIN X, Zhu YP, Luo CJ, Zhou M, et al
    Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6-7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years.
    Ann Hematol. 2021 May 14. pii: 10.1007/s00277-021-04540.
    PubMed     Abstract available

  112. BALLAS SK
    Opioids are not a major cause of death of patients with sickle cell disease.
    Ann Hematol. 2021;100:1133-1138.
    PubMed     Abstract available

    April 2021
  113. MENDOZA E, Duque X, Moran S, Martinez-Andrade G, et al
    Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants.
    Ann Hematol. 2021;100:879-890.
    PubMed     Abstract available

  114. RAMSAY Z, Gabbadon CH, Asnani M
    Numb chin syndrome in sickle cell disease: a case series of Jamaican patients.
    Ann Hematol. 2021;100:913-919.
    PubMed     Abstract available

  115. HATAIRAKTHAM S, Masaratana P, Hantaweepant C, Srisawat C, et al
    Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent beta-thalassemia/Hb E patients.
    Ann Hematol. 2021;100:891-901.
    PubMed     Abstract available

    March 2021
  116. YOUSSEF JG, Zahiruddin F, Youssef G, Padmanabhan S, et al
    G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
    Ann Hematol. 2021;100:667-673.
    PubMed     Abstract available

  117. SAEIDNIA M, Nowrouzi-Sohrabi P, Erfani M, Fazeli P, et al
    The effect of curcumin on serum copper, zinc, and zinc/copper ratio in patients with beta-thalassemia intermedia: a randomized double-blind clinical trial.
    Ann Hematol. 2021;100:627-633.
    PubMed     Abstract available

  118. VERMA HK, Ratre YK, Bhaskar LVKS, Colombatti R, et al
    Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy.
    Ann Hematol. 2021;100:607-614.
    PubMed     Abstract available

  119. HAGHPANAH S, Cohan N, Bordbar M, Bazrafshan A, et al
    Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent beta-thalassemia.
    Ann Hematol. 2021;100:635-644.
    PubMed     Abstract available

  120. SCHULLER H, Klein F, Lubbert M, Prager EP, et al
    Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report.
    Ann Hematol. 2021;100:841-842.

  121. MISTRY RH, Kohut A, Ford P
    Correction of iron deficiency in hospitalized heart failure patients does not improve patient outcomes.
    Ann Hematol. 2021;100:661-666.
    PubMed     Abstract available

    February 2021
  122. HSIEH TC, Sostin O
    Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids.
    Ann Hematol. 2021 Feb 18. pii: 10.1007/s00277-021-04457.

  123. HATZLHOFER BLD, Pereira-Martins DA, de Farias Domingos I, Arcanjo GDS, et al
    Alpha thalassemia, but not beta(S)-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort.
    Ann Hematol. 2021 Feb 13. pii: 10.1007/s00277-021-04450.
    PubMed     Abstract available

  124. LADEIRA VS, Barbosa AR, Oliveira MM, Ferreira LGR, et al
    ADAMTS-13-VWF axis in sickle cell disease patients.
    Ann Hematol. 2021;100:375-382.
    PubMed     Abstract available

  125. KUMAR R, Yadav R, Mishra S, Singh MPSS, et al
    Kruppel-like factor 1 (KLF1) gene single nucleotide polymorphisms in sickle cell disease and its association with disease-related morbidities.
    Ann Hematol. 2021;100:365-373.
    PubMed     Abstract available

  126. BATISTA JVGF, Arcanjo GS, Batista THC, Sobreira MJ, et al
    Influence of UGT1A1 promoter polymorphism, alpha-thalassemia and beta(s) haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort.
    Ann Hematol. 2021 Feb 1. pii: 10.1007/s00277-021-04422.
    PubMed     Abstract available

    January 2021
  127. MARTYNOVA A, Chiu V, Mert M, Hermel D, et al
    Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series.
    Ann Hematol. 2021 Jan 9. pii: 10.1007/s00277-021-04401.
    PubMed     Abstract available

  128. STACY S, Sheth S, Coleman B, Cerenzia W, et al
    An assessment of the continuing medical education needs of US physicians in the management of patients with beta thalassemia.
    Ann Hematol. 2021;100:27-35.
    PubMed     Abstract available

    December 2020
  129. GIORDANO G, Napolitano M, Di Battista V, Lucchesi A, et al
    Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study.
    Ann Hematol. 2020 Dec 2. pii: 10.1007/s00277-020-04361.
    PubMed     Abstract available

  130. WU Y, Yao Q, Zhong M, Wu J, et al
    Genetic research and clinical analysis of deletional Chinese (G)gamma(+)((A)gammadeltabeta)(0) -thalassemia and Southeast Asian HPFH in South China.
    Ann Hematol. 2020;99:2747-2753.
    PubMed     Abstract available

  131. SINHA S, Jit BP, Patro ARK, Ray A, et al
    Influence of rs1042713 and rs1042714 polymorphisms of beta2-adrenergic receptor gene with erythrocyte cAMP in sickle cell disease patients from Odisha State, India.
    Ann Hematol. 2020;99:2737-2745.
    PubMed     Abstract available

  132. PAZGAL I, Yahalom V, Shalev B, Raanani P, et al
    Alloimmunization and autoimmunization in adult transfusion-dependent thalassemia patients: a report from a comprehensive center in Israel.
    Ann Hematol. 2020;99:2731-2736.
    PubMed     Abstract available

    November 2020
  133. MENDEZ M, Moreno-Carralero MI, Peri VL, Camacho-Galan R, et al
    Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene.
    Ann Hematol. 2020 Nov 7. pii: 10.1007/s00277-020-04319.
    PubMed     Abstract available

  134. RUAN J, Zuo W, Chen M, Yang C, et al
    Correction to: Eltrombopag is effective in patients with relapse/refractory aplastic anemia-report from a single center in China.
    Ann Hematol. 2020 Nov 2. pii: 10.1007/s00277-020-04301.
    PubMed     Abstract available

  135. ABDULLAH N, Ismail N, Abd Jalal N, Mohd Radin F, et al
    Prevalence of anaemia and associated risk factors amongst The Malaysian Cohort participants.
    Ann Hematol. 2020;99:2521-2527.
    PubMed     Abstract available

  136. DESAI RJ, Mahesri M, Globe D, Mutebi A, et al
    Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiaries.
    Ann Hematol. 2020;99:2497-2505.
    PubMed     Abstract available

  137. BALLAS SK, Dampier C
    Risk factors associated with increased emergency department utilization in patients with sickle cell disease: a systematic literature review.
    Ann Hematol. 2020;99:2483-2495.
    PubMed     Abstract available

  138. KIRITO K
    Expansion of paroxysmal nocturnal hemoglobinuria clones in MPLW515L mutation harboring primary myelofibrosis.
    Ann Hematol. 2020;99:2707-2709.

  139. TRIPATHI P, Agarwal S, Gupta A, Mandal K, et al
    Biallelic rare 17 bp deletion mutation (HBB:c.380_396 del TGCAGGCTGCCTATCAG) in a transfusion depended form of thalassemia.
    Ann Hematol. 2020;99:2719-2722.

    October 2020
  140. WAN K, Yin Y, Luo Z, Cheng J, et al
    Correction to: Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia.
    Ann Hematol. 2020 Oct 16. pii: 10.1007/s00277-020-04300.
    PubMed     Abstract available

  141. ONISHI Y, Mori T, Yamazaki H, Takenaka K, et al
    Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia.
    Ann Hematol. 2020 Oct 9. pii: 10.1007/s00277-020-04290.
    PubMed     Abstract available

  142. LAN Y, Chang L, Yi M, Cai Y, et al
    Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine.
    Ann Hematol. 2020 Oct 8. pii: 10.1007/s00277-020-04296.
    PubMed     Abstract available

  143. ONISHI Y, Yokoyama H, Katsuoka Y, Ito T, et al
    Low-dose lenalidomide and dexamethasone therapy after melphalan-prednisolone induction in elderly patients with newly diagnosed multiple myeloma.
    Ann Hematol. 2020;99:2351-2356.
    PubMed     Abstract available

  144. FUREDER W, Sperr WR, Heibl S, Zebisch A, et al
    Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network.
    Ann Hematol. 2020;99:2303-2313.
    PubMed     Abstract available

  145. BUTTARI B, Profumo E, Caprari P, Massimi S, et al
    Phenotypical and functional abnormalities of circulating neutrophils in patients with beta-thalassemia.
    Ann Hematol. 2020;99:2265-2277.
    PubMed     Abstract available

  146. EL-GHAMRAWY M, Yassa ME, Tousson AMS, El-Hady MA, et al
    Association between BCL11A, HSB1L-MYB, and XmnI gammaG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
    Ann Hematol. 2020;99:2279-2288.
    PubMed     Abstract available

  147. CHUANG TY, Li JP, Weng TF, Wu KH, et al
    Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications.
    Ann Hematol. 2020;99:2289-2294.
    PubMed     Abstract available

  148. FRIEDRICH C, Gay J, Alary AS, Arlet JB, et al
    Battle of the clones: paroxysmal nocturnal hemoglobinuria vs myelodysplastic syndrome.
    Ann Hematol. 2020;99:2459-2461.

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.